...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Interesting New Lipid Standards

golf, even though the SUSTAIN and ASSURE phase 2b trials overall data showed that RVX-208 raises ApoA-I/HDL and represses pro-inflammatory, pro-atherosclerotic and pro-thrombotic pathways that can contribute to CVD risk, this is not enough to market apabetalone on its own for this specific health benefit. Crazy eh! 

 

Koo

 

 

 

Share
New Message
Please login to post a reply